Urinary Bladder, Overactive: all 864 studies

Page 2 of 9. Open to participants first (125), then studies with results posted, then the rest; newest registration first within each.

• Safety and Efficacy of Botulinum Toxin A for Treatment of Overactive Bladder in Parkinson's DiseaseRecruitingNCT05997043Early Phase 1
• Evaluation the Efficacy Between Botox Injection and Combination Pharmacotherapy in Patients With Detrusor OveractivityRecruitingNCT05968885Phase 4
• Does Position Influence the Diagnosis of Detrusor Overactivity in a Neurological PopulationRecruitingNCT05949567Not applicable
• Comparisons of the Impact of Monotherapy With Mirabegron or Tolterodine Versus Combined Treatment With Mirabegron and Tolterodine on Autonomic Function and Bladder Blow Flow in Women With Overactive Bladder Syndrome: a Randomized Controlled StudyRecruitingNCT05946902Phase 4
• Prostate Enucleation With Intravesical Botox Injections in Treating BPH and Bladder OveractivityNot yet recruitingNCT05910983Not applicable
• Diversity in Patients With OABNot yet recruitingNCT05903105
• Lower Urinary Tract Symptoms After Intravesical TherapyRecruitingNCT05844059
• Efficacy of Electroacupuncture Versus Solifenacin Succinate for Female Overactive BladderRecruitingNCT05798403Not applicable
• Clinical and Urodynamic Assessment of Bladder Sensation in Multiple SclerosisRecruitingNCT05772637Not applicable
• A Real World Study of eCoin for Urgency Urinary Incontinence: Post Approval Evaluation (RECIPE)RecruitingNCT05685433Not applicable
• Noninvasive Ultrasound Assessment of Detrusor DysfunctionRecruitingNCT05652023
• The Treatment Efficacy of Prolotherapy in Bladder Voiding DysfunctionRecruitingNCT05485142Not applicable
• TReating Incontinence for Underlying Mental and Physical HealthRecruitingNCT05362292Phase 4
• HRT on Overactive Bladder Symptoms, Sexual Function, Depressive Symptoms, Autonomic Function, and Arterial StiffnessRecruitingNCT05280028
• Vaginal Estradiol vs Oral Beta-3 Agonist for Overactive Bladder SyndromeRecruitingNCT05221021Phase 4
• Pelvic Health Electrically Evoked Recording (PEER) 2 StudyRecruitingNCT05200923Not applicable
• Acupuncture for Overactive Bladder in AdultsRecruitingNCT05158361Not applicable
• The Effectiveness of Parassacral Transcutaneous Stimulation Compared to Tibial Transcutaneous Stimulation, Home Protocol and Behavioral Therapy in the Treatment of Female Hyperative Bladder: Randomized Clinical TrialRecruitingNCT04909047Not applicable
• BTL Emsella Chair Versus Sham for the Treatment of Overactive BladderRecruitingNCT04873037Not applicable
• Antibiotic Usage Prior to OnabotulinumtoxinA InjectionRecruitingNCT04754737Not applicable
• Fluoroscopy Radiation Reduction During Sacral Neuromodulation Lead PlacementRecruitingNCT04527445Not applicable
• Post-procedural Pain Associated With 5 Versus 20 Intravesical Injections of Onabotulinumtoxin ARecruitingNCT04305743Phase 4
• Pharmacologic Effect for Female Overactive Bladder Syndrome: Mirabegron Versus SolifenacinRecruitingNCT04023253Phase 3
• Standard Injections Versus Reduced Injections for Intravesical onabotulinumtoxinA Treatment of Overactive BladderRecruitingNCT04020510Phase 4
• The Use of cineMRI to Evaluate Botox in Patients With Medication Refractory Overactive BladderRecruitingNCT02315950Not applicable
• Optimization of OnabotulinumtoxinA (BTX-A) Injection for the Treatment of Neurogenic Lower Urinary Tract DysfunctionCompletedNCT06059066Not applicableResults posted
• Modern Urodynamics System Efficacy (MUSE) StudyCompletedNCT05959655Not applicableResults posted
• A Pilot Study to Assess Effects of Self-Administered Nitrous Oxide (SANO) on Urodynamic Study (UDS) ParametersCompletedNCT05883332Phase 4Results posted
• Lidocaine Patches Prior to Percutaneous Nerve EvaluationCompletedNCT05783219Phase 2Results posted
• Prophylactic Antibiotic Administration for Bladder OnabotulinumtoxinA InjectionCompletedNCT05719285Phase 4Results posted
• Procedural Discomfort Related to Number of Intradetrusor Botox InjectionsCompletedNCT05652036Phase 4Results posted
• PTNS for Female Patients Suffering From Multiple SclerosisTerminatedNCT05422625Not applicableResults posted
• Intradetrusor Botulinum Toxin A for OAB Via 1 Versus 10 Injections: A Randomized Clinical TrialCompletedNCT05308979Phase 4Results posted
• Evaluation of Implantable Tibial Neuromodulation Pivotal Study (TITAN 2)CompletedNCT05226286Not applicableResults posted
• Axonics SacRal NeuromodulaTIon System RegisTRY StudyCompletedNCT05064384Results posted
• Posterior Tibial Nerve Stimulation (PTNS) Plus Mirabegron to Treat Refractory OAB Symptoms (PTNS-M Study)CompletedNCT04907032Phase 4Results posted
• A Study to Evaluate Mirabegron in Pediatric Participants From 5 to Less Than 18 Years of Age With Overactive Bladder (OAB)TerminatedNCT04641975Phase 3Results posted
• Feasibility of Parasacral Transcutaneous Electrical Nerve Stimulation PTENS for Voiding Dysfunction in Peds PopulationCompletedNCT04570605Not applicableResults posted
• A Study With Mirabegron 50 mg and 25 mg in Chinese Participants With Overactive BladderCompletedNCT04562090Phase 4Results posted
• FREEOAB Study for Overactive BladderCompletedNCT04547920Not applicableResults posted
• Study to Gather Information About the Actual Use of an Adhesive Patch Placed on the Skin to Deliver Oxytrol Through the Skin Into the Bloodstream.CompletedNCT04534491Phase 3Results posted
• InterStim Micro Post Market Clinical Follow-up Study (ELITE)TerminatedNCT04506866Not applicableResults posted
• TENS Used for Pain Management During Office Cystoscopy Botox InjectionsTerminatedNCT04448171Not applicableResults posted
• Impact of Decision Aids in UrogynecologyCompletedNCT04369404Not applicableResults posted
• Minimizing Pain During Office Intradetrussor Botox InjectionCompletedNCT04270526Phase 4Results posted
• URO-902 in Female Subjects With Overactive Bladder and Urge Urinary IncontinenceCompletedNCT04211831Phase 2Results posted
• Is 10 Injections of Bladder Botox Less Painful Than 20 Injections?CompletedNCT04124939Phase 4Results posted
• Clinical Feasibility Study, Implantable Tibial Nerve Stimulator (ITNS)CompletedNCT04115228Not applicableResults posted
• Extension Study of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic HyperplasiaCompletedNCT04103450Phase 3Results posted
• InterStim Basic Evaluation Lead Post-Market Clinical Follow-up StudyCompletedNCT04016324Not applicableResults posted
• Fall Prevention in Older Adults With OABCompletedNCT03946124Phase 4Results posted
• Study to Evaluate the Efficacy, Safety and Tolerability of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH)CompletedNCT03902080Phase 3Results posted
• Laser Therapy for Treatment of Urogenital Symptoms in WomenCompletedNCT03681678Results posted
• eCoin for OAB Feasibility Follow-on StudyCompletedNCT03655054Not applicableResults posted
• Posterior Tibial Nerve Stimulation's Effectiveness in UI Frequency in Overactive Patients in HomeCompletedNCT03595215Not applicableResults posted
• An Extension Study to Examine the Safety and Tolerability of a New Drug in Patients With Symptoms of Overactive Bladder (OAB).CompletedNCT03583372Phase 3Results posted
• Efficacy and Safety Evaluating Study to Compare Uritos® (Imidafenacin) and Urotol® (Tolterodine) for Treatment of Overactive Bladder.CompletedNCT03575702Phase 3Results posted
• Pivotal Study of eCoin for Overactive Bladder With Urgency Urinary IncontinenceCompletedNCT03556891Not applicableResults posted
• Sham Controlled Trial of Rapid Induction Percutaneous Tibial Nerve StimulationCompletedNCT03547518Not applicableResults posted
• Effectiveness of Bilateral PTNS Compared to Unilateral PTNS for the Treatment of Overactive Bladder/Urge IncontinenceTerminatedNCT03535857Not applicableResults posted
• OnabotulinumtoxinA Bladder Injection StudyTerminatedNCT03523091Phase 4Results posted
• Comparison of Methods for Prevention of Urinary Tract Infection Following Botox InjectionTerminatedNCT03508921Phase 4Results posted
• A Study to Examine the Safety and Efficacy of a New Drug in Patients With Symptoms of Overactive Bladder (OAB)CompletedNCT03492281Phase 3Results posted
• BOTOX® Intravesical Instillation in Participants With Overactive Bladder and Urinary IncontinenceCompletedNCT03320850Phase 2Results posted
• Exploratory Study of TAC-302 in Detrusor Underactivity Patients With Overactive Bladder.CompletedNCT03175029Phase 2Results posted
• Behavioral or Solifenacin Therapy for Urinary Symptoms in Parkinson DiseaseCompletedNCT03149809Phase 3Results posted
• Evaluation of an Alternative Injection Paradigm for OnabotulinumtoxinA (BOTOX®) in the Treatment of Overactive Bladder in Patients With Urinary IncontinenceCompletedNCT03052764Phase 4Results posted
• Central Nervous System Changes Following OnabotulinumtoxinA Injection in the BladderCompletedNCT03033355Results posted
• Evaluation of Botulinum Toxin A Alone Versus Botulinum Toxin A With Hydrodistension for Treatment of Overactive BladderTerminatedNCT02995967Not applicableResults posted
• Mirabegron For Erectile DysfunctionCompletedNCT02916693Phase 1/2Results posted
• Timing of B and O Suppositories to Help Relieve Post-operative Bladder SpasmsTerminatedNCT02865395Phase 4Results posted
• PRospective Study to Evaluate EffectivenesS With the NURO™ PErcutaneous Tibial Neuromodulation System in Patients With OABCompletedNCT02857816Not applicableResults posted
• Efficacy and Safety Study of GSK1358820 in Japanese Patients With Urinary Incontinence Due to Neurogenic Detrusor OveractivityCompletedNCT02849418Phase 3Results posted
• Investigation of the Effect of the Female Urinary Microbiome on IncontinenceCompletedNCT02835846Phase 4Results posted
• Efficacy and Safety of GSK1358820 in Subjects With Overactive BladderCompletedNCT02820844Phase 3Results posted
• A Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Men With OAB Symptoms While Taking Tamsulosin Hydrochloride for Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH)CompletedNCT02757768Phase 4Results posted
• Open-label Phase 3 Study With Mirabegron in Children From 3 to Less Than 18 Years of Age With Neurogenic Detrusor OveractivityCompletedNCT02751931Phase 3Results posted
• Percutaneous Nerve Evaluation With Fluoroscopy Versus WithoutCompletedNCT02677753Not applicableResults posted
• Dysport® Treatment of Urinary Incontinence in Adults Subjects With Neurogenic Detrusor Overactivity (NDO) Due to Spinal Cord Injury or Multiple Sclerosis - Study 2TerminatedNCT02660359Phase 3Results posted
• Dysport® Treatment of Urinary Incontinence in Adults Subjects With Neurogenic Detrusor Overactivity (NDO) Due to Spinal Cord Injury or Multiple Sclerosis - Study 1TerminatedNCT02660138Phase 3Results posted
• A Phase 4 Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Male Subjects With Overactive Bladder (OAB) Symptoms, While Taking the Alpha Blocker for Benign Prostatic Hypertrophy (BPH)CompletedNCT02656173Phase 4Results posted
• Reduction of Bladder Injection Pain With Belladonna Opiate SuppositoryCompletedNCT02600715Phase 4Results posted
• Mirabegron in Parkinson Disease and Impaired CognitionCompletedNCT02536976Phase 4Results posted
• The Estrogen Impact on Overactive Bladder Syndrome: Female Pelvic Floor Microbiomes and Antimicrobial PeptidesCompletedNCT02524769Not applicableResults posted
• A Trial of Transcutaneous Nerve Stimulation for OABCompletedNCT02511717Not applicableResults posted
• Open-label Long-term Extension Study of Fesoterodine in Japanese Subjects With Neurogenic Detrusor Overactivity.CompletedNCT02501928Phase 3Results posted
• Mirabegron and Urinary Urgency IncontinenceCompletedNCT02495389Phase 4Results posted
• Add-on Mirabegron in Pediatric Patients With Refractory Overactive BladderCompletedNCT02476175Phase 3Results posted
• Pilot Study of Mirabegron in Pediatric Patients With Overactive BladderCompletedNCT02468830Phase 3Results posted
• Myrbetriq™ (Mirabegron) to Reduce Pain and Discomfort Following Ureteral Stent PlacementTerminatedNCT02462837Phase 2Results posted
• The Effect of Urox™ in the Treatment of Overactive Bladder and Urinary IncontinenceCompletedNCT02396160Not applicableResults posted
• Postmarketing Study to Evaluate add-on Therapy With Anticholinergics in Patients With Overactive Bladder (OAB) on Mirabegron.CompletedNCT02294396Phase 4Results posted
• Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Older Adult Subjects With Overactive Bladder (OAB)CompletedNCT02216214Phase 4Results posted
• Controlling Urgency Through Relaxation ExercisesCompletedNCT02202031Not applicableResults posted
• A Study to Evaluate Tolerability and Participants Preference Between Mirabegron and Tolterodine Extended Release (ER) in Participants With Overactive Bladder (OAB)CompletedNCT02138747Phase 4Results posted
• OnabotulinumtoxinA for the Treatment of Urinary Incontinence Due to Overactive Bladder in Pediatric Patients (12 to 17)TerminatedNCT02097121Phase 3Results posted
• A Pilot Study of Mirabegron and Behavioral Modification Including Pelvic Floor Exercise for Overactive Bladder in Parkinson's Disease (MAESTRO)CompletedNCT02092181Phase 4Results posted
• A Multinational Study Comparing the Long-term Efficacy and Safety of Two Medicines, Solifenacin Succinate and Mirabegron Taken Together, or Separately, in Subjects With Symptoms of Overactive BladderCompletedNCT02045862Phase 3Results posted
• A Clinical Study to Investigate How Solifenacin Fluid is Taken up, How Long it Stays in the Body and How Effective and Safe it is in Treating Children Aged From 6 Months to Less Than 5 Years With Symptoms of Neurogenic Detrusor Overactivity (NDO)CompletedNCT01981954Phase 3Results posted
• This Was a Multinational Study Comparing the Efficacy and Safety of Two Medicines , Solifenacin Succinate and Mirabegron Taken Together, or Separately, or a Mock Treatment (Placebo) in Subjects With Symptoms of Overactive BladderCompletedNCT01972841Phase 3Results posted

← Urinary Bladder, Overactive overview